farnaz shokraneh | personalized medicine | Best Researcher Award

Posted on by ScienceFather

Ms. farnaz shokraneh | personalized medicine | Best Researcher Award

Abo Akademi University, Finland

👨‍🎓Professional Profile 

Orcid Profile

👩‍🔬 Summary

Ms. Farnaz Shokraneh is an experienced pharmaceutical professional currently working as a Doctoral Researcher in Pharmaceutical Development and Medical Technology at Ă…bo Akademi University in Turku, Finland. With a solid academic background and extensive practical experience in pharmaceutical quality assurance, regulatory compliance, and research, she brings valuable insights into the development of pharmaceutical products and systems. She is committed to advancing personalized medicine and improving quality control in the pharmaceutical industry.

🎓 Education

Ms. Shokraneh holds a Doctor of Pharmacy degree, equivalent to a Finnish Master’s, from Islamic Azad University, Tehran, Iran (2007-2012). She furthered her academic journey with a Master’s in Pharmaceutical Research from Freie Universität Berlin, Germany (2022-2024). Currently, she is pursuing her doctoral research in Pharmaceutical Development and Medical Technology at Åbo Akademi University, Turku, Finland (2022–present).

đź’Ľ Professional Experience

Ms. Shokraneh has accumulated extensive experience in various roles within the pharmaceutical industry. She is currently serving as a Quality Manager at CurifyLabs Oy in Helsinki, Finland, since September 2022. Previously, she held the position of Quality Assurance Manager at Mofid Pharma under the license of Bayer Pharmaceutical Company (Dec 2020–Dec 2021). Additionally, she has worked at Modava Pharmaceutical under Novartis (Jul 2018–Jul 2020) and ATI Pharmed Pharmaceutical Co under StragenPharma and CHEMO Pharmaceutical licenses (Apr 2013–Jun 2017).

🛠️ Technical Skills

Ms. Shokraneh’s technical expertise encompasses pharmaceutical development, quality assurance, and regulatory compliance. She is proficient in analytical techniques such as HPLC, mass spectrometry, and micro NIR spectrophotometry. Her experience also extends to pharmacovigilance, safety monitoring, and statistical analysis for pharmaceutical applications, making her highly skilled in ensuring the safety, efficacy, and quality of pharmaceutical products.

🧑‍🏫 Teaching Experience

Although Ms. Shokraneh’s current focus is on research and industry roles, her vast knowledge and experience in the pharmaceutical field allow her to effectively mentor teams and share her expertise. She has contributed to the professional development of her colleagues and participated in educational training programs within the pharmaceutical sector.

🔬 Research Interests

Ms. Shokraneh’s primary research interests lie in pharmaceutical development and medical technology, with a particular focus on personalized medicine. She is passionate about improving drug safety and efficacy through innovations in automated pharmacy compounding, quality control, and exploring new methods for drug delivery and patient-specific treatment plans.

 

đź“–Top Noted Publications

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets

Authors: Niklas Sandler Topelius, Farnaz Shokraneh, Mahsa Bahman, Julius Lahtinen, Niko Hassinen, Sari Airaksinen, Soumya Verma, Ludmila Hrizanovska, Jana Lass, Urve Paaver et al.

Journal: Pharmaceutics

Year: 2024

A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design

Authors: Farnaz Shokraneh

Journal: Iranian Journal of Pharmaceutical Research

Year: 2014

Comparative Studies of Cytotoxic Manufacturing Practices in Specialized Cancer Centers Against International Guidelines (ASHP, OSHA, HSE-UK)

Authors: Farnaz Shokraneh

Journal: FIP Congress

Year: 2012

Development and Validation of High-Performance Liquid Chromatography for Determination of Nystatin in Pharmaceutical Formulations

Authors: Farnaz Shokraneh

Journal: Research in Pharmaceutical Science

Year: 2012

A New HPLC Method for Determination of Losartan in Human Plasma and Its Application in Bioequivalence Studies

Authors: Farnaz Shokraneh

Journal: Oriental Journal of Chemistry

Year: 2012

Risks to Health Professionals from Hazardous Drugs in Iran: A Pilot Study of Understanding of Healthcare Team to Occupational Exposure to Cytotoxics

Authors: Farnaz Shokraneh

Journal: EXCLI Journal

Year: 2005

Kirsten Tolstrup | medicine | Best Researcher Award

Posted on by ScienceFather

Dr. Kirsten Tolstrup | Medicine | Best Researcher Award

Doctorate at UCSF School of Medicine, United States

👨‍🎓Professional Profile

👩‍⚕️ Summary

Dr. Kirsten Tolstrup is a distinguished cardiologist with extensive experience in cardiovascular disease, adult comprehensive echocardiography, and women’s heart health. With certifications in Internal Medicine, Cardiovascular Disease, and Echocardiography, she has held leadership roles at prominent institutions such as UCSF, Cedars-Sinai, and UNM. She is currently the Associate Chief of Cardiology at UCSF and serves as the Interim Medical Director of the HVC in the Division of Cardiology.

🎓 Education

Dr. Tolstrup completed her MD at the University of Copenhagen, Denmark, in 1993. She holds a BS from the University of Copenhagen, obtained in 1988. She pursued her Internal Medicine Residency at USC-LAC Medical Center in Los Angeles (1995-1998) and completed a Cardiovascular Medicine Fellowship at the UNM Health Sciences Center in Albuquerque (1998-2001).

đź’Ľ Professional Experience

Throughout her career, Dr. Tolstrup has held key roles, including Associate Chief of Cardiology at UCSF (2020-present), Medical Director of the Heart Station and Echo Laboratory at UNM (2012-2016), and Director of the Cardiac Non-invasive Stress Laboratory at Cedars-Sinai (2009-2012). She has also served as an Associate Clinical Professor at UCLA and Professor of Medicine at UCSF.

đź“š Academic Citations

Dr. Tolstrup has made significant academic contributions, authoring chapters in notable medical texts such as Current Diagnosis and Treatment in Cardiology and The Ultimate Echo Guide. She has contributed to clinical guidelines on the use of echocardiography for cardiac embolism and heart disease in pregnancy.

🛠️ Technical Skills

She is highly skilled in adult comprehensive echocardiography and non-invasive cardiovascular imaging, with expertise in cardiac diagnostics and advanced echocardiographic techniques. Her technical proficiency also extends to cardiovascular risk assessment and imaging.

👩‍🏫 Teaching Experience

Dr. Tolstrup has shared her knowledge through teaching roles, including as a Teaching Associate at UCLA and Professor of Medicine at UCSF. She also served as an Instructor/Master at Dynamic Taekwondo Academy and remains actively involved in mentoring and instructing future cardiologists.

🔬 Research Interests

Her research interests focus on cardiovascular imaging, particularly in the areas of women’s heart health, aortic diseases, and heart failure. Dr. Tolstrup is dedicated to advancing the clinical applications of echocardiography and understanding cardiovascular risks across diverse populations.

đź“–Top Noted Publications

Very low prevalence and incidence of atrial fibrillation among Bolivian forager-farmers

Authors: Rowan, C.J., Eskander, M.A., Seabright, E., Kaplan, H.S., Gurven, M.D.
Journal: Annals of Global Health
Year: 2021

Update on Bicuspid Aortic Valve Syndrome: Patient Selection and Therapies in 2020

Authors: Anderson, D., Grober, A., Mahadevan, V., Tolstrup, K.
Journal: Current Treatment Options in Cardiovascular Medicine
Year: 2020

The clinical application of the ratio of transmitral early filling velocity to early diastolic strain rate: a systematic review and meta-analysis

Authors: Lassen, M.C.H., Olsen, F.J., Skaarup, K.G., Gislason, G., Biering-Sørensen, T.
Journal: Journal of Echocardiography
Year: 2020

 A Case-Based Discussion on the Management of Cryptogenic Stroke and Patent Foramen Ovale in the Patient With a Hypercoagulable Disorder

Authors: Gerstein, N.S., Clegg, S.D., Levin, D.B., Yoshida, Y., Homma, S.
Journal: Journal of Cardiothoracic and Vascular Anesthesia
Year: 2019

Ratio of transmitral early filling velocity to early diastolic strain rate predicts long-term risk of cardiovascular morbidity and mortality in the general population

Authors: Lassen, M.C.Hø., Biering-Sørensen, S.R., Olsen, F.J., Jensen, J.S., Biering-Sørensen, T.
Journal: European Heart Journal
Year: 2019

Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism

Authors: Saric, M., Armour, A.C., Arnaout, M.S., Michelena, H.I., Tolstrup, K.
Journal: Journal of the American Society of Echocardiography
Year: 2016